Previous Article | Next Article 
Molecular and Cellular Biology, February 1999, p. 1569-1581, Vol. 19, No. 2
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
The MKK7 Gene Encodes a Group of c-Jun
NH2-Terminal Kinase Kinases
Cathy
Tournier,
Alan J.
Whitmarsh,
Julie
Cavanagh,
Tamera
Barrett, and
Roger J.
Davis*
Howard Hughes Medical Institute and Program
in Molecular Medicine and Department of Biochemistry and Molecular
Biology, University of Massachusetts Medical School, Worcester,
Massachusetts 01605
Received 27 April 1998/Returned for modification 3 June
1998/Accepted 4 November 1998
 |
ABSTRACT |
The c-Jun NH2-terminal protein kinase (JNK) is a member
of the mitogen-activated protein kinase (MAPK) group and is an
essential component of a signaling cascade that is activated by
exposure of cells to environmental stress. JNK activation is regulated by phosphorylation on both Thr and Tyr residues by a dual-specificity MAPK kinase (MAPKK). Two MAPKKs, MKK4 and MKK7, have been identified as
JNK activators. Genetic studies demonstrate that MKK4 and MKK7 serve
nonredundant functions as activators of JNK in vivo. We report here the
molecular cloning of the gene that encodes MKK7 and demonstrate that
six isoforms are created by alternative splicing to generate a group of
protein kinases with three different NH2 termini (
,
,
and
isoforms) and two different COOH termini (1 and 2 isoforms).
The MKK7
isoforms lack an NH2-terminal extension that is
present in the other MKK7 isoforms. This NH2-terminal extension binds directly to the MKK7 substrate JNK. Comparison of the
activities of the MKK7 isoforms demonstrates that the MKK7
isoforms
exhibit lower activity, but a higher level of inducible fold
activation, than the corresponding MKK7
and MKK7
isoforms. Immunofluorescence analysis demonstrates that these MKK7 isoforms are
detected in both cytoplasmic and nuclear compartments of cultured cells. The presence of MKK7 in the nucleus was not, however, required for JNK activation in vivo. These data establish that the
MKK4 and MKK7 genes encode a group of protein
kinases with different biochemical properties that mediate activation
of JNK in response to extracellular stimuli.
 |
INTRODUCTION |
Mitogen-activated protein kinases
(MAPKs) are components of pathways that relay signals to particular
cell compartments in response to a diverse array of extracellular
stimuli (38, 42, 63, 83). Activated MAPK can translocate to
the nucleus and phosphorylate substrates, including transcription
factors, thereby eliciting a biological response. At least three groups
of MAPKs have been identified in mammals: ERK (extracellular
signal-regulated kinase), JNK (c-Jun N-terminal kinase; also known as
stress-activated protein kinase), and p38 MAPK (also known as
cytokine-suppressive anti-inflammatory drug-binding protein). ERK
contributes to the response of cells to signals initiated by many
growth factors and hormones through a Ras-dependent pathway
(63). In contrast, JNK and p38 MAPK are activated by
environmental stresses, such as UV radiation, osmotic shock, heat
shock, protein synthesis inhibitors, and lipopolysaccharide (38,
83). The JNK and p38 MAP kinases are also activated by treatment
of cells with proinflammatory cytokines, including interleukin-1 (IL-1)
and tumor necrosis factor alpha (TNF-
) (38, 83). MAPKs
are involved in the control of a wide spectrum of cellular processes
including growth, differentiation, survival, and death (38,
63).
MAPKs are activated by conserved protein kinase signaling modules which
include a MAPK kinase kinase (MAPKKK) and a dual-specificity MAPK
kinase (MAPKK). The MAPKKK phosphorylates and activates the MAPKK
which, in turn, activates the MAPK by dual phosphorylation on threonine
and tyrosine residues within a Thr-Xaa-Tyr motif located in protein
kinase subdomain VIII (38, 63). Separate protein kinase
signaling modules are used to activate different groups of MAPKs
(13). The MAPKKK and MAPKK that activate the ERK MAP kinases
include c-Raf-1 and MEK1, respectively (63). The c-Raf-1
protein kinase activity is regulated by the small GTPase Ras, which
induces translocation of c-Raf-1 to the plasma membrane, where it is
thought to be activated (63). In contrast, JNK and p38 MAPK
appear to be activated by small GTPases of the Rho family (3, 10,
49, 59, 91). The mechanism by which Rho GTPases activate the JNK
and p38 MAPK signaling pathways is unclear. Although Rho GTPases
interact with the PAK group of STE20-related protein kinases, it
appears that JNK and p38 MAP kinase activation may be mediated, in
part, by the mixed-lineage group of protein kinases (MLK) (62,
74) or by the scaffold protein POSH (72). STE20-like
protein kinases represent possible targets for other upstream signals
that lead to JNK activation. Among the STE20-like protein kinases, the
hematopoietic progenitor kinase 1 (HPK1) (2, 37, 41, 79) and
the kinase homologous to STE20/SPS1 (KHS) (78) appear to
specifically activate JNK. There is evidence for significant complexity
in the mechanism of initiation of the JNK and p38 MAPK signaling
pathways because of the large number of MAPKKK protein kinases that
contribute to stress-activated MAPK signaling (19, 38).
Whether there is a general or a specific role for Rho family GTPases in
the activation of the JNK and p38 MAP kinase signaling pathways has not
been established.
The protein kinases that have been reported to act as MAPKKKs for the
JNK signaling pathway include the MEK/ERK kinase (MEKK) group, the MLK
group, TPL-2, ASK1, and TAK1 (19, 38). The MEKK group of
MAPKKKs includes MEKK1 (43, 50, 86), MEKK2 (6,
11), MEKK3 (6, 11, 15), MEKK4/MTK1 (25,
71), and MAPKKK5/MEKK5 (80). The MLK group of MAPKKKs
includes MLK1 (14), MLK2/MST (14, 33), MLK3/SPRK
(62, 74, 75), dual-leucine zipper-bearing kinase (DLK)/MUK
(18, 32), and leucine zipper-bearing kinase (LZK)
(64). Binding sites for the Rho family GTPases Cdc42 and
Rac1 have been described for MLK1, MLK2, and MLK3 (but not DLK or LZK)
(7). It has also been reported that MEKK1 and MEKK4 (but not
MEKK2 or MEKK3) bind directly to the Rho family GTPases Cdc42 and Rac1
(20). These interactions between Rho GTPases and MAPKKKs may
contribute to the effects of Rho GTPases on JNK activation. MAPKKK
protein kinases that do not interact with Rho GTPases may mediate the
effects of Rho-independent signals that lead to JNK activation.
Several MAPKKs have been identified. ERK is activated by MEK1 and MEK2
(1); p38 MAPK is activated by MKK3 (13), MKK4 (13, 45), and MKK6 (28, 53, 61, 68); JNK is
activated by MKK4 (13, 45, 65). The existence of JNK
activators distinct from MKK4 was suggested by chromatographic
fractionation of cell extracts (48, 52) and by the results
of targeted disruption of the MKK4 gene (58, 87).
We (76) and others (21, 34, 36, 44, 46, 55, 77, 84,
89) have recently characterized the novel JNK activator MKK7. In
contrast to MKK4, which activates both JNK and p38 MAPK, the MKK7
protein kinase selectively activates only JNK. Interestingly, the two
JNK activators D-MKK4 (Drosophila MKK4) (29) and
Hep/D-MKK7 (26, 67) are conserved in Drosophila. Genetic analysis demonstrates that D-MKK4 and Hep/D-MKK7 serve nonredundant functions in the fly (38). Similarly, gene
disruption experiments demonstrate that MKK4 is an essential
gene in the mouse, indicating that MKK7 is unable to fully substitute
for the function of MKK4 (24, 57, 58, 70, 87). These data demonstrate that MKK4 and MKK7 serve nonredundant functions as activators of the JNK MAP kinases in vivo.
We report here the molecular cloning of the MKK7 gene and
the characterization of MKK7 isoforms that are created by alternative splicing. The MKK7 isoforms are differentially activated by upstream signals, and their regulation differs from that of the MKK4 isoforms. These data establish that JNK activation is mediated by a family of
protein kinases that are formed by the alternative splicing of two genes.
 |
MATERIALS AND METHODS |
Materials.
Human TNF-
and IL-1
were from Genzyme Corp.
[
-32P]ATP was obtained from Amersham Corp. Recombinant
glutathione S-transferase (GST)-c-Jun and GST-JNK1 were
purified from bacteria as described elsewhere (12).
Mammalian expression vectors for MKK4 isoforms (13) and
MKK7
1 (76) have been described elsewhere. MKK4
includes an additional 34 amino acids fused to the NH2
terminus of MKK4 (13). The expression vectors pCMV-HA-MEK1
and pCMV-HA-
N3-MEK1-EE were provided by N. Ahn (47). The
expression vectors pEBG-KHS (78), pSR
-HPK1
(37), pMT2T-MEKK3 (15), pCDNAI-MTK1/MEKK4 (71), pCDNA3-MLK3 (74), and pSR
-DLK
(33) were provided by J. Blenis, T. Tan, U. Siebenlist, H. Saito, S. Gutkind, and J. Avruch, respectively.
Molecular cloning of MKK7 isoforms.
Genomic DNA clones
corresponding to the MKK7 locus were isolated by screening a
FixII murine genomic library (Stratagene, Inc.), using
the MKK7
1 cDNA as a probe. The genomic sequence of MKK7 was obtained
with an Applied Biosystems model 373A machine. To identify additional
MKK7 isoforms, a mouse testis cDNA library cloned in the phage
ZAPII
(Stratagene, Inc.) was screened by using the MKK7
1 cDNA as a probe.
Positive clones were plaque purified and sequenced. The MKK7 isoforms
were subcloned into the mammalian expression vectors pCDNA3 (Invitrogen
Inc.) and pEBG (86). The Flag epitope
(Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys; Immunex Corp.) was fused to the
NH2 terminus of the MKK7 isoforms by insertional
overlapping PCR (35). A nuclear export signal (NES) sequence
(23) corresponding to residues 32 to 51 of MEK1 (Ala-Leu-Gln-Lys-Lys-Leu-Glu-Glu-Leu-Glu-Leu-Asp-Glu-Gln-Gln-Arg-Lys-Arg-Leu-Glu) was inserted following the Flag epitope, by using a PCR-based procedure
to create NES-MKK7 isoforms. Bacterial expression of MKK7 was performed
with the vector pGEX-4T-1 (Pharmacia-LKB Biotechnology, Inc.).
FISH.
Lymphocytes isolated from male mouse spleen were used
for chromosome fluorescence in situ hybridization analysis (FISH)
(30, 31). Metaphase chromosomes spread on a glass slide were
air dried, baked at 55°C (1 h), and digested with RNase A. The DNA was denatured for 2 min at 70°C in 70% formamide in 2× SSC (1× SSC
is 0.15 M NaCl plus 0.015 M sodium citrate) and dehydrated with
ethanol. DNA prepared from a mouse MKK7 genomic clone was biotinylated and used as the hybridization probe (30). The
FISH and 4',6-diamidino-2-phenylindole (DAPI) staining were recorded on
film. The assignment of the FISH mapping data with chromosomal bands
was achieved by superimposing the FISH signals with images of the
DAPI-banded chromosomes.
Tissue culture and transfection assays.
COS-7 and 293 cells
were cultured at 37°C in Dulbecco's modified Eagle's medium
supplemented with 10% heat-inactivated fetal bovine serum (Life
Technologies, Inc.), 2 mM glutamine, 100 U of penicillin per ml, and
100 U of streptomycin per ml in a humidified environment with 5%
CO2. Transient transfections were performed with the
LipofectAMINE reagent (Life Technologies) according to the
manufacturer's recommendations. After 36 h, the cells were serum
starved for 1 h and treated with UV-C (80 J/m2),
anisomycin (5 µg/ml), TNF-
(20 ng/ml), or IL-1
(2 to 10 ng/ml) for 30 min prior to lysis. Cell extracts were prepared in lysis buffer
(20 mM Tris [pH 7.4], 10% glycerol, 1% Triton X-100, 0.137 M NaCl,
25 mM
-glycerophosphate, 2 mM EDTA, 1 mM sodium orthovanadate, 10 µg of leupeptin per ml, 10 µg of aprotinin per ml, 1 mM
phenylmethylsulfonyl fluoride) and centrifuged at 15,000 × g (15 min at 4°C). The concentration of total soluble
protein in the supernatant was quantitated by the Bradford method
(Bio-Rad).
Binding assays.
GST-tagged MKK7 proteins were isolated by
incubation with glutathione (GSH)-Sepharose (Pharmacia-LKB
Biotechnology) in lysis buffer (4 h at 4°C). The beads were washed
five times with lysis buffer, and the presence of bound JNK was
examined by immunoblot analysis.
Protein kinase assays.
Epitope-tagged MAPKK was
immunoprecipitated from cell extracts by incubation for 3 h at
4°C with the Flag-specific monoclonal antibody M2 (IBI-Kodak) bound
to protein G-Sepharose beads (Pharmacia-LKB Biotechnology). GST-tagged
MAPKK was isolated by incubation for 3 h at 4°C with
GSH-Sepharose beads (Pharmacia-LKB Biotechnology). The complexes were
washed twice with lysis buffer and three times with kinase buffer (25 mM HEPES [pH 7.4], 25 mM
-glycerophosphate, 25 mM
MgCl2, 0.5 mM dithiothreitol, 0.1 mM sodium orthovanadate). MAPKK activity was measured at 30°C for 20 min in 30 µl of kinase buffer containing 0.5 µg of GST-JNK1, 2 µg of GST-c-Jun, and 50 µM [
-32P]ATP (10 Ci/mmol; 1 Ci = 37.6 GBq). The
reactions were terminated by addition of Laemmli sample buffer.
Proteins were resolved by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE 10% polyacrylamide gel) and identified by
autoradiography. The incorporation of [32P]phosphate into
GST-c-Jun was quantitated by PhosphorImager analysis.
JNK protein kinase assays were performed with extracts of cells
transfected with HA-JNK1. The JNK was immunoprecipitated with an
antibody to the HA epitope tag (12CA5; Boehringer Mannheim). Protein
kinase activity was measured in the immune complex with c-Jun as the
substrate (12).
Western blot analysis.
Proteins were resolved by SDS-PAGE
(10% gel), electrophoretically transferred to an Immobilon-P membrane
(Millipore Inc.), and probed with the Flag-specific monoclonal antibody
M2 (1:4000; IBI-Kodak) or a monoclonal antibody to MKK4 (1:1000;
Pharmingen). Immune complexes were detected by enhanced
chemiluminescence (Lumiglo; Kirkegaard & Perry Laboratories).
Immunofluorescence microscopy.
COS-7 cells were seeded onto
glass coverslips coated with poly-L-lysine (Sigma Chemical
Co.); 36 h after transfection, the cells were fixed for 10 min
with 4% paraformaldehyde in phosphate-buffered saline (PBS) and then
permeabilized for 5 min with 0.2% Triton X-100 in PBS. After
incubation for 15 min with 3% (wt/vol) bovine serum albumin (BSA) in
PBS, the coverslips were incubated for 1 h with primary antibodies
in PBS with 3% BSA. The primary antibodies were rabbit anti-MKK4
(K-18; 1:100; Santa Cruz Biotechnology), goat anti-MKK7 (C-18; 1:100;
Santa Cruz), rabbit anti-phosphorylated (on Thr-183 and Tyr-185) JNK
(phospho-JNK) (9251; 1:100; New England Biolabs Inc.), and monoclonal
antibodies (1:500) to Flag (M2) and HA (12CA5). Immune complexes were
detected with Texas red-conjugated anti-mouse immunoglobulin (Ig),
Texas red-conjugated anti-goat Ig, rhodamine-conjugated anti-rabbit Ig,
and fluorescein-conjugated anti-rabbit Ig antibodies (1:100; Jackson
ImmunoResearch, Inc.) in 3% BSA in PBS. After nuclei were stained for
1 min with DAPI (1:10,000; Molecular Probes, Inc.), the coverslips were
mounted in Vectashield (Vector Laboratories, Inc.). All procedures were performed at room temperature. Fluorescence microscopy was performed with a Zeiss Axioplan microscope.
Nucleotide sequence accession numbers.
The sequences of the
murine MKK7 cDNA clones have been deposited in GenBank with accession
no. U93030, AF060943, AF060944, AF060945, AF060946, and AF060947.
 |
RESULTS |
Molecular cloning of MKK7 isoforms.
MKK7 has recently been
identified as a specific activator of the JNK group of MAPKs. Northern
blot analysis demonstrated the presence of at least two MKK7
mRNAs (2.2 and 4.2 kb) in adult murine tissues (76), an
observation which suggested that MKK7 may be expressed as a group of
alternatively spliced isoforms. To characterize members of the MKK7
group, we exhaustively screened a mouse testis cDNA library by using
our original MKK7 clone (MKK7
1) as a probe. This analysis led to the
identification of additional isoforms: MKK7
2, MKK7
1, MKK7
2,
MKK7
1, and MKK7
2 (Fig. 1). The
predicted amino acid sequences are identical except at the NH2 terminus (
,
, and
isoforms) and at the COOH
terminus (1 and 2 isoforms).

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 1.
Primary structures of MKK7 protein kinase isoforms. The
primary sequence of the mouse MKK7 protein kinase isoforms deduced from
the sequences of cDNA clones are presented in single-letter code.
Residues that are identical to those in MKK7 2 (.), deletions ( ),
and termination codons (#) are indicated.
|
|
We isolated a murine genomic clone that encodes the MKK7 protein kinase
isoforms. FISH analysis led to the mapping of the gene to mouse
chromosome 11 region A2 (Fig. 2).
Sequence analysis of the gene demonstrated the presence of 14 exons
(Fig. 3). Sequence comparison of the gene with cDNA encoding the MKK7
isoforms demonstrated that these isoforms are created by the usage of
alternative exons. This analysis indicated that MKK7 is a
complex gene that expresses a group of MKK7 protein kinases.

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 2.
The MKK7 gene is located on mouse chromosome
11. The MKK7 gene was identified by FISH analysis of murine
metaphase chromosomes by using an MKK7 genomic clone as a
probe. The FISH signal is illustrated on the left (arrow). The
corresponding DAPI signal indicating chromosome 11 is shown on the
right. Detailed comparison of DAPI-banded chromosome 11 with the FISH
signal indicated that the MKK7 gene is located in region
A2.
|
|
Initiation codons in frame with upstream termination codons are located
in separate exons in the 5' region of the MKK7 gene. The
isoforms are created by using an initiation codon located in exon 4 in
frame with an upstream termination codon located in exon 3 (Fig.
3). In contrast, the initiation codon
(together with an upstream in-frame termination codon) used to create
the
and
isoforms is located in exon 1. Alternative splicing
which includes or excludes exon 2 distinguishes the
and
isoforms (Fig. 3).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 3.
Schematic representation of the structure of the
MKK7 gene. The MKK7 gene is formed by 14 exons.
The alternative splicing that creates the , , , 1, and 2 isoforms of MKK7 is illustrated. The coding (black) and noncoding
(grey) regions and excluded exons (striped) are shown. Initiation
codons (ATG), termination codons (*), and polyadenylation signals
( ) are indicated.
|
|
Alternative splicing in the 3' region of the gene changes the usage of
termination codons to create a truncated COOH terminus (1 isoforms) and
an extended COOH terminus that includes 33 additional amino acids (2 isoforms). The truncated COOH terminus results from the presence of an
in-frame termination codon and a polyadenylation signal in exon 13 (Fig. 3). Alternative splicing within exon 13 immediately prior to this
termination codon fuses the open reading frame to sequences located in
exon 14. This fusion creates the longer COOH terminus that is
characteristic of the 2 isoforms. A termination codon and a
polyadenylation signal are located in exon 14.
Comparison of protein kinase activities of MKK7 isoforms.
We
used a coupled protein kinase assay in vitro to examine the protein
kinase activities of MKK7 isoforms that were isolated from transfected
mammalian cells. This assay employs bacterially expressed JNK1 as a
substrate for the MKK7 protein kinases. The activation of JNK1 by MKK7
was examined by using bacterially expressed c-Jun as a substrate for
JNK. Control experiments indicated that MKK7 does not phosphorylate
c-Jun (data not shown). These assays demonstrated that the activities
of the MKK7
and MKK7
isoforms were similar and that the
alternative splicing at the COOH terminus of MKK7 (1 and 2 isoforms)
did not markedly alter protein kinase activity (Fig.
4). In contrast, activities of the
MKK7
isoforms were lower than those of the MKK7
and MKK7
isoforms. Quantitation of the MKK7 activity by PhosphorImager analysis
indicated that MKK7
1 was 37-fold more active than MKK7
1.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 4.
Effects of MKK7 homologs on JNK activation. (A) COS-7
cells were transfected with expression vectors encoding Flag
epitope-tagged MKK7 1, MKK7 2, MKK7 1, MKK7 2, MKK7 1, or
MKK7 2. The expression of each of these MKK7 isoforms was examined by
immunoblot (IB) analysis using the Flag-specific monoclonal antibody
M2. The MKK7 isoforms were immunoprecipitated, and their activities
were measured in the immune complex by a coupled protein kinase assay
(KA) using recombinant GST-JNK1 and GST-c-Jun as substrates. The
phosphorylated c-Jun was detected after SDS-PAGE by autoradiography and
was quantitated by PhosphorImager analysis. The effect of
cotransfection with an empty expression vector ( ) or with an MEKK1
expression vector (+) is shown. Similar results were observed in three
separate experiments. (B) MKK7 activity, presented as relative protein
kinase activity. (C) MKK7 activation caused by MEKK1 (fold activity
over MKK7 activity in the absence of MEKK1).
|
|
The difference in protein kinase activity of the MKK7 isoforms was
detected under basal conditions (Fig. 4). To determine whether similar
differences could be detected following activation, we examined the
effect of a strong activator of the JNK signaling pathway (MEKK1). We
found that MEKK1 caused marked activation of all the MKK7 isoforms. The
largest increase was observed for MKK7
1 and MKK7
2, which were
activated by 34- and 20-fold, respectively (Fig. 4). The MKK7
and
MKK7
protein kinases were activated more modestly (three- fivefold).
These data demonstrate that the MKK7
and MKK7
isoforms are more
active than MKK7
isoforms (under basal conditions and following
activation) but that the MKK7
isoforms are more inducible following
stimulation. The low basal activity of the MKK7
isoforms accounts,
in part, for their greater activation.
Together, these data demonstrate that the activity of MKK7 isoforms is
affected by alternative splicing of the NH2-terminal region
but not by alternative splicing of the COOH-terminal region. However,
the inclusion or exclusion of exon 2 within the
NH2-terminal region of MKK7 (
and
isoforms) did not
alter MKK7 protein kinase activity in these assays.
The NH2-terminal region of MKK7
interacts with
JNK.
The observation that activities of the MKK7
isoforms were
lower than those of the MKK7
and MKK7
isoforms suggests that these MKK7 isoforms may differentially interact with the substrate JNK.
To test this hypothesis, we examined the interaction of MKK7
and
MKK7
isoforms with JNK1 following expression in COS-7 cells. We
precipitated the MKK7 protein kinases from cell lysates, and examined
the presence of JNK1 in the precipitates by immunoblot analysis (Fig.
5A). These assays demonstrated that
MKK7
isoforms, but not MKK7
isoforms, coprecipitated with JNK.
This binding interaction may contribute to the higher activities of
MKK7
isoforms than of MKK7
isoforms (Fig. 4).

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 5.
Interaction of JNK with MKK7 isoforms. (A) Selective
binding of MKK7 isoforms to JNK. Epitope-tagged JNK1 and either GST
(Control) or GST-tagged MKK7 1, MKK7 2, MKK7 1, or MKK7 2 were
expressed in COS-1 cells. Protein expression levels, monitored by
immunoblot analysis of the cell lysates, were similar in all
transfections. The MKK7 protein kinases were isolated from cell
extracts by incubation with GSH-agarose. The binding of JNK1 was
examined by immunoblot analysis with an antibody to the HA epitope tag.
(B) JNK binds to the NH2 terminus of MKK7 . Bacterially
expressed GST (Control) or a GST fusion protein (residues 1 to 73 of
MKK7 ) was immobilized on GSH-agarose and incubated with extracts
prepared from COS-7 cells expressing epitope-tagged JNK1. The agarose
beads were washed, and the amount of bound JNK1 was examined by
immunoblot analysis.
|
|
The MKK7
and MKK7
isoforms differ structurally by virtue of an
NH2-terminal extension that is present in MKK7
but not
MKK7
. This NH2-terminal region of MKK7
therefore
accounts for the binding interaction observed between JNK and MKK7
.
The mechanism by which this NH2-terminal region alters the
binding to JNK is unclear. The NH2-terminal region may act
indirectly by altering the conformation of another region of the MKK7
protein kinase that binds JNK. Alternatively, JNK may bind directly to
the NH2 terminus of MKK7
. To test the latter hypothesis,
we expressed the NH2-terminal region of MKK7
(residues 1 to 73) as a GST fusion protein in bacteria. This recombinant protein
was found to bind JNK (Fig. 5B). These data demonstrate that the
MKK7
isoforms bind JNK and indicate that this is mediated, in part,
by a direct interaction between JNK and the NH2-terminal region of MKK7
that is absent in MKK7
. The presence of a region in the NH2 terminus of MKK7
that binds JNK is consistent
with previous studies that have implicated the NH2-terminal
region of MAPKK in the determination of signaling specificity to
distinct MAPK isoforms (4).
Regulation of MKK7 isoforms by MAPKKKs.
The protein kinases
MEKK1, MLK3, and DLK preferentially activate JNK (32, 33, 50, 62,
74, 75, 86), MEKK3 activates both JNK and ERK (6, 11,
15), while MEKK4 has been reported to activate both JNK and p38
MAPK (25, 71). Since MEKK1 causes differential activation of
MKK7 isoforms (Fig. 4), we examined whether other MAPKKKs, including
members of the MEKK and MLK groups (19), could also cause
differential activation of MKK7 isoforms.
To test the effects of various MAPKKK isoforms on activation of MKK7
isoforms, we examined MEKK and MLK protein kinases in cotransfection
assays. Control experiments demonstrated that MEKK1, MEKK3, MLK3, and
DLK caused similar increases in JNK activity (Fig.
6). However, MEKK4 caused no JNK
activation (Fig. 6), in contrast to a previous report (25).
Instead, MEKK4 selectively activated p38 MAPK (data not shown). These
data identify MEKK4 as an activator of the p38 MAPK pathway
(71).

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 6.
Effect of MEKK and STE20 protein kinases on JNK
activation. To examine the ability of MAPKKKs and STE20 homologs to
activate JNK1, COS-7 cells were cotransfected with a mammalian
expression vector encoding HA-tagged JNK1 together with an empty
expression vector (Control) or an expression vector encoding either
MEKK1, MEKK3, MEKK4, MLK3, DLK, KHS, or HPK1. The expression of JNK1
was examined by immunoblot (IB) analysis using a monoclonal antibody to
the HA epitope tag. JNK1 was immunoprecipitated and its activity was
measured in the immune complex by a protein kinase assay (KA) using
recombinant GST-c-Jun as the substrate. The phosphorylated c-Jun was
detected after SDS-PAGE by autoradiography and was quantitated by
PhosphorImager analysis. JNK activity is presented as relative protein
kinase activity. The levels of JNK activation caused by MEKK1, MEKK3,
MEKK4, MLK3, DLK, KHS, and HPK1 were 28-, 29-, 2.0-, 24-, 30-, 5.3-, and 4.3-fold, respectively. Similar results were obtained in three
separate experiments.
|
|
To compare the levels of activation of MKK4 and MKK7 isoforms by
different MAPKKKs, we performed coupled protein kinase assays. MKK4 and
MKK7 activity was detected with bacterially expressed JNK1 as the
substrate, and JNK activation was assessed by measurement of the
phosphorylation of c-Jun. Protein immunoblot analysis demonstrated that
similar amounts of MKK7 were examined in all assays (Fig. 7). While MEKK1, MEKK3, MLK3, and DLK
efficiently activated JNK (Fig. 6), these MAPKKKs displayed differences
in the ability to activate MKK4 and MKK7 isoforms. For example, MEKK1
was the most potent activator of MKK7 isoforms, whereas MEKK3 was the
most potent activator of MKK4 isoforms (Fig. 7). MEKK1, MLK3 and DLK caused similar increases in MKK4 and MKK4
activity. The extent of
activation of MKK7 isoforms by MEKK3 was largest for MKK7
1, while
the MKK7
2 isoform was only weakly activated by MEKK3. However, the
MKK7
isoforms were activated by the mixed-lineage kinases DLK and
MLK3 more strongly than by MEKK3. The decreased electrophoretic mobility of MKK7
2 (and MKK7
isoforms to a lesser extent) caused by MEKK1 and MEKK3 was not caused by MLK3 or DLK (Fig. 7). Together, these data demonstrate that MEKK1, MEKK3, MLK3, and DLK are capable of
selectively activating MKK4 and MKK7 protein kinase isoforms.

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 7.
Activation of MKK4 and MKK7 protein kinases by MAPKKKs.
To examine the abilities of MAPKKKs to activate MKK isoforms, COS-7
cells were cotransfected with mammalian expression vectors encoding
tagged MKK7 1, MKK7 2, MKK7 1, MKK7 2, MKK4, or MKK4
together with either an empty expression vector (Control) or an
expression vector encoding MEKK1, MEKK3, MEKK4, MLK3, or DLK. MKK
protein expression was monitored by immunoblot (IB) analysis. The MKK4
and MKK7 isoforms were immunoprecipitated, and their activities were
measured by a coupled protein kinase assay (KA) using recombinant JNK1
and c-Jun as substrates. The phosphorylated c-Jun was detected after
SDS-PAGE by autoradiography and was quantitated by PhosphorImager
analysis. MAPKK activity is presented as relative protein kinase
activity. The levels of MAPKK activation caused by MEKK1, MEKK3, MEKK4,
MLK3, and DLK were 27-, 19-, 1.8-, 5.0-, and 7.0-fold (MKK7 1); 32-, 10-, 1.4-, 13-, and 6.5-fold (MKK7 2); 5.6-, 2.0-, 0.3-, 4.2-, and
4.5-fold (MKK7 1); 13-, 2.6-, 1.3-, 7.5-, and 5.1-fold (MKK7 2);
42-, 88-, 2.0-, 38-, and 39-fold (MKK4); and 53-, 77-, 2.2-, 48-, and
36-fold (MKK4 ), respectively. Similar results were obtained in three
separate experiments.
|
|
Consistent with the observation that MEKK4 did not activate JNK (Fig.
6), we found that MEKK4 did not activate any of the MKK4 or MKK7
isoforms (Fig. 7).
Regulation of MKK4 and MKK7 isoforms by STE20-like protein
kinases.
Several STE20-like protein kinases have been reported to
be capable of activating the JNK pathway (19). Among them,
KHS (78) and HPK1 (37, 41, 79) appear to be
specific for the JNK signaling pathway. We therefore examined the
abilities of KHS and HPK1 to activate MKK4 and MKK7 isoforms. Cells
were transiently transfected with expression vectors encoding
epitope-tagged MKK4 or MKK7 isoforms, together with expression vectors
for either KHS or HPK1. Control experiments demonstrated that the KHS
and HPK1 protein kinases caused similar levels of JNK activation (Fig. 6). The amount of MKK4 and MKK7 protein expression was examined by
Western blot analysis (Fig. 8). The MKK4
and MKK7 protein kinases were immunoprecipitated, and their activities
were measured by a coupled protein kinase assay. KHS and HPK1 caused
similar increases in the activities of MKK7
1, MKK7
2, and MKK4.
However, differences in the activation of MKK4
and MKK7
isoforms
were detected. Indeed, HPK1 was the most potent activator of MKK7
1
and MKK7
2, while KHS was the most potent activator of MKK4
.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 8.
Activation of MKK4 and MKK7 protein kinases by STE20
homologs. To examine the abilities of KHS and HPK1 to activate MKK7
isoforms, COS-7 cells were cotransfected with Flag-tagged MKK7 1,
MKK7 2, MKK7 1, MKK7 2, MKK4, or MKK4 together with an empty
expression vector (Control) or an expression vector for either KHS or
HPK1. Protein expression was monitored by immunoblot (IB) analysis.
Flag-tagged MKKs were immunoprecipitated, and MKK activity was measured
in the immune complex by a coupled protein kinase assay (KA) using
recombinant JNK1 and c-Jun as substrates. The phosphorylated c-Jun was
detected after SDS-PAGE by autoradiography and quantitated by
PhosphorImager analysis. MAPKK activity is presented as relative
protein kinase activity. The levels of MAPKK activation caused by KHS
and HPK were 15- and 31-fold (MKK7 1); 3.9- and 15-fold (MKK7 2);
4.0- and 3.5-fold (MKK7 1); 5.4- and 4.4-fold (MKK7 2); 3.2- and
2.9-fold (MKK4); and 4.4- and 2.4-fold (MKK4 ), respectively. Similar
results were obtained in three separate experiments.
|
|
Regulation of MKK4 and MKK7 protein kinases by extracellular
stimuli.
To identify the nature of the MKKs involved in the
regulation of the JNK cascade in response to specific extracellular
stimuli, we examined the effects of environmental stresses and
proinflammatory cytokines on activation of MKK4 and MKK7 protein kinase
activities. We found that MKK4 and MKK7 isoforms were selectively
regulated by upstream kinases (Fig. 7 and 8). Therefore, we examined
the effects of UV-C radiation, anisomycin, TNF-
, and IL-1
on the regulation of MKK7 and MKK4 isoforms. The MKK4 and MKK7 isoforms were
isolated, and their activity was measured by a coupled kinase assay.
TNF
and IL-1
selectively activated the MKK7 isoforms and only
weakly activated MKK4 (Fig. 9). In
contrast, UV-C radiation and anisomycin caused selective activation of
MKK4 compared to MKK7 (Fig. 9). These data indicate that the MKK4 and
MKK7 isoforms are selectively regulated by specific extracellular
stimuli. This selective regulation is consistent with the genetic
evidence for nonredundant roles of MKK4 and MKK7 in
Drosophila and mammals (38).

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 9.
Regulation of MKK4 and MKK7 protein kinases by
extracellular stimuli. 293 cells were transiently transfected with
expression vectors (pEBG) encoding either MKK7 1, MKK7 2, MKK7 1,
MKK7 2, MKK4, or MKK4 ; 36 h after transfection, the cells
were untreated (Control) or treated with UV-C (UV; 80 J/m2), anisomycin (ANISO; 5 µg/ml), TNF- (20 ng/ml),
or IL-1 (2 ng/ml). The cells were harvested after incubation at
37°C (30 min). MKK4 and MKK7 were isolated by using GSH-Sepharose
beads, and the MKK activity was measured by a coupled protein kinase
assay using recombinant JNK1 and c-Jun as substrates. The radioactivity
incorporated into c-Jun was quantitated after SDS-PAGE by
PhosphorImager analysis. MAPKK activity is presented as relative
protein kinase activity. The levels of MAPKK activation caused by UV,
anisomycin, TNF- , and IL-1 were 1.4-, 1.5-, 2.2-, and 1.9-fold
(MKK7 1); 2.8-, 1.8-, 3.9-, and 2.5-fold (MKK7 2); 2.4-, 2.1-, 2.5-, and 4.1-fold (MKK7 1); 2.0-, 1.7-, 2.8-, and 2.9-fold
(MKK7 2); 4.7-, 3.2-, 0.9-, and 0.9-fold (MKK4); and 2.6-, 2.3-, 0.9-, and 0.9-fold (MKK4 ), respectively. Similar results were
obtained in three separate experiments.
|
|
Subcellular localization of MKK4 and MKK7 protein kinases.
JNK
has been reported to accumulate in the nucleus upon treatment of cells
with stimuli known to activate the JNK signaling pathway (8, 40,
51). We therefore examined the subcellular localization of MKK4
and MKK7 by immunofluorescence analysis. These studies demonstrated
that the endogenous MKK4 and MKK7 protein kinases were distributed in
both the cytoplasm and the nucleus (Fig.
10A). Exposure of
the cells to UV-C radiation or treatment with IL-1
did not cause
marked changes in the distribution of the endogenous MKK4 or MKK7
protein kinases.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 10.
Subcellular distribution of MAPKK isoforms. (A)
Endogenous MKK4 and MKK7 (red) were detected by immunofluorescence
analysis using primary antibodies specific for these MKK isoforms. The
cells were untreated (Control) or treated (30 min) with UV (80 J/m2) or IL-1 (10 ng/ml). DNA was visualized by staining
with DAPI (blue). The scale bar (white) represents 20 µm. (B)
Epitope-tagged MKK7 1, MKK7 2, MKK7 1, MKK7 2, MKK4, MKK4 ,
MEK1, and N3-MEK1-EE were detected by using a primary monoclonal
antibody to the epitope tag and a Texas red-labeled secondary antibody.
The scale bar (white) represents 10 µm.
|
|
To examine the subcellular localization of individual MKK4 and MKK7
isoforms, we transfected cells with epitope-tagged MKK4 and MKK7 and
also performed control experiments with epitope-tagged wild-type MEK1
and constitutively activated MEK1 (
N3-MEK1-EE). The activated MEK1
was constructed by replacing the two activating phosphorylation sites
with glutamic acid residues and by deletion of the
NH2-terminal NES (22, 23, 39, 47).
Immunofluorescence analysis demonstrated that, as expected, wild-type
MEK1 was restricted to the cytoplasm, while activated MEK1 was present
in the nucleus (Fig. 10B). Under the same experimental conditions, the
MKK4 and MKK7 isoforms were detected at low levels in the cytoplasm and appeared to preferentially accumulate in the nucleus (Fig. 10B). The
higher level of nuclear accumulation of the transfected MAPKK than of
the endogenous MAPKK may reflect the overexpression of the recombinant
proteins. Exposure of the cells to UV-C radiation or treatment with
IL-1
did not induce changes in the localization of MKK4 or MKK7
(data not shown).
Effect of nuclear exclusion on the activity of MKK7.
The
distribution of the MKK7 protein in the cytoplasm and the nucleus
differs from that described for the ERK MAPK activator MEK1. While the
endogenous MKK7 protein appears to preferentially accumulate in the
nucleus (Fig. 10A), MEK1 is excluded from the nucleus. The mechanism of
nuclear exclusion is mediated by the presence of an NES in the
NH2-terminal region of MEK1 (23). Disruption of
the NES causes nuclear accumulation of MEK1 and marked potentiation of
signaling (22). These data suggest that the NES may be important for the normal control of MEK1 activity.
To test whether the presence of an NES would affect the properties of
MKK7, we fused the NES of MEK1 to the NH2-terminal region of MKK7
(Fig. 11A).
Immunofluorescence analysis demonstrated that while MKK7
2
preferentially accumulated in the nucleus, the NES-MKK7
2 was
excluded from the nucleus (Fig. 11B). Similar results were obtained in
experiments using MKK7
1 and NES-MKK7
1 (data not shown).

View larger version (14K):
[in this window]
[in a new window]

View larger version (26K):
[in this window]
[in a new window]

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 11.
Effect of an NES on the properties of MKK7. (A)
Schematic representation of MKK7 and NES-MKK7 . Both proteins were
constructed with an NH2-terminal Flag epitope (grey box).
The nuclear export signal (NES) of MEK1 (residues 32 to 51) was
inserted following the Flag epitope to create NES-MKK7 . (B) The MKK7
proteins and HA-JNK1 were expressed in COS-7 cells. Transfected cells
were identified by immunofluorescence analysis using antibody M2, which
binds the Flag epitope on the MKK7 proteins. Activated JNK in the
transfected cells was examined by using an antibody to phospho-JNK
[JNK(P)]. The MKK7 (red) and phospho-JNK (green) were detected with
secondary antibodies conjugated to Texas red and fluorescein,
respectively. DNA was visualized by staining with DAPI (blue). The
scale bar (white) represents 10 µm. (C) Regulation of MKK7 2 and
NES-MKK7 2 by extracellular stimuli. COS-7 cells expressing MKK7 2
or NES-MKK7 2 were untreated (Control) or treated (30 min) with UV-C
(80 J/m2) or IL-1 (10 ng/ml). The expression of MKK7 was
examined by immunoblot (IB) analysis using the Flag-specific monoclonal
antibody M2. MKK7 activity was measured in a coupled protein kinase
assay (KA). The radioactivity incorporated into c-Jun was quantitated
after SDS-PAGE by PhosphorImager analysis. MAPKK activity is presented
as relative protein kinase activity. The levels of MAPKK activation
caused by UV and IL-1 were 3.0- and 3.7-fold (MKK7 2) and 1.5- and
1.8-fold (NES-MKK7 2), respectively. (D) Activation of JNK1 by
MKK7 and NES-MKK7 . COS-7 cells were cotransfected with plasmids
expressing HA-tagged JNK1 together with an empty vector (Control) or an
expression vector encoding Flag-tagged MKK7 1, NES-MKK7 1,
MKK7 2, or NES-MKK7 2. The expression of MKK7 and JNK1 was
monitored by immunoblot (IB) analysis using antibodies to Flag and HA,
respectively. JNK1 activity was measured by immune complex kinase assay
(KA) using the substrate c-Jun. The radioactivity incorporated into
c-Jun was quantitated after SDS-PAGE by PhosphorImager analysis. JNK
activity is presented as relative protein kinase activity. The levels
of JNK activation observed for MKK7 1, NES-MKK7 1, MKK7 2, and
NES-MKK7 2 were 21-, 27-, 25-, and 31-fold, respectively.
|
|
The presence of an NES may alter the activation of MKK7 by cytokines or
by environmental stresses. We therefore examined the effects of UV-C
radiation and IL-1
on the activation of MKK7
2 and NES-MKK7
2
(Fig. 11C), using a coupled protein kinase assay to measure the MKK7
protein kinase activity. Western blot analysis demonstrated the
expression of similar amounts of MKK7
2 and NES-MKK7
2. Protein
kinase assays demonstrated that both MKK7
2 and NES-MKK7
2 were
activated by UV-C radiation and IL-1
. These data demonstrated that
extracellular stimuli can activate MKK7 proteins that are preferentially located either in the nucleus (MKK7
2) or in the cytoplasm (NES-MKK7
2).
The presence of an NES might also alter the effect of MKK7 on JNK. To
examine JNK activation, we performed immunofluorescence analysis using
an antibody that binds to JNK phosphorylated on Thr-183 and Tyr-185.
Control experiments demonstrated that the exposure of cells to UV-C
radiation caused increased staining by the phospho-JNK antibody (data
not shown). Expression of either MKK7
2 or NES-MKK7
2 also caused
increased staining by the phospho-JNK antibody. Immunofluorescence
analysis demonstrated that the activated JNK accumulated in the nucleus
(Fig. 11B). Quantitative assays of protein kinase activity using
biochemical methods demonstrated that MKK7
1, MKK7
2, NES-MKK7
1,
and NES-MKK7
2 caused a similar level of JNK activation (Fig. 11D).
These data indicated that recombinant MKK7 molecules that are
preferentially located in the nucleus (MKK7
2) or in the cytoplasm
(NES-MKK7
2) are equally capable of activating the JNK MAPK. This
observation contrasts with the previous finding that constitutively
nuclear MEK1 mutants cause enhanced signaling by the ERK MAPK
(22).
 |
DISCUSSION |
The genes that encode the JNK activators MKK4 and MKK7 are located
on mouse chromosome 11.
The MKK7 gene was mapped to
mouse chromosome 11 (Fig. 2). It is interesting that the
MKK4 gene is also located on this chromosome (81). The localization of both of the genes that encode JNK activators on the same mouse chromosome suggests that these genes might
be linked. This is an interesting possibility because MKK4 is a candidate tumor suppressor gene that is mutated in certain tumors
(73), suggesting that the MKK7 gene may also be a
target of genetic alterations in disease processes.
Although the mouse MKK4 and MKK7 genes reside on
the same chromosome, it does not appear that this relationship is
present in all species. Thus, in Drosophila, the
D-MKK4 (29) and D-MKK7 (26)
genes are located on different chromosomes. Indeed, it appears that the
D-MKK3 gene (and not the D-MKK4 gene) is tightly linked to the D-MKK7 gene in the fly (29). The
colocalization of the genes that encode the JNK activators MKK4 and
MKK7 on one mouse chromosome is therefore not evolutionarily conserved.
The MKK7 gene encodes a group of protein kinases.
The MKK7 gene includes 14 exons. Alternative splicing leads
to the inclusion or exclusion of exons located in the 5' and 3' regions
of the gene, resulting in the expression of a group of MKK7 isoforms
that differ in their NH2 and COOH termini (Fig. 3). These
MKK7 protein kinase isoforms act as activators of JNK MAPK. Comparative
studies demonstrate that the MKK7 isoforms differ in the extent of
activation in response to different upstream components of the JNK
signaling pathway (Fig. 7 to 9).
Sequences in the NH2 termini of MAPKK protein kinases have
been reported to mediate specific interactions with other components of
MAPK pathways (4). Similarly, specificity determinants have been identified in the NH2- and COOH-terminal regions of
MAPK pathway components, including PBS2 and MEKK1 (60, 69,
85). It is therefore interesting that multiple cDNA clones with
different 5' regions have been reported for MKK3, MKK4, MKK5, and MKK6
(13, 17, 28, 54, 61, 65, 90). Whether these different cDNA clones correspond to fully processed mRNA is unclear because the corresponding genes have not been characterized. In contrast, it is
established that the usage of alternative exons within the MKK7 gene leads to the formation of multiple protein kinase
isoforms (Fig. 3). It is therefore likely that the expression of a
group of alternatively spliced isoforms is a common property of MAPKK genes. The possible role of the divergent NH2-terminal
sequences of MAPKK isoforms as specificity determinants for MAPKK
function (4) suggests that different MAPKK isoforms may have
different physiological functions. In this study, we demonstrate that
the NH2-terminal extension that is present in the MKK7
isoforms, but not MKK7
isoforms, binds to the substrate JNK and may
account, in part, for the differences in activity between these MKK7
isoforms (Fig. 4 and 5). This binding to JNK is consistent with the
presence of consensus primary sequence motifs for JNK interaction
(Leu-Xaa-Leu) in the NH2-terminal region of MKK7
(88).
The MKK7 group of protein kinases are present in the cytoplasm and
the nucleus.
Studies of the ERK MAPK signaling pathway demonstrate
that the ERK MAPKs are present in the cytoplasm of quiescent cells and that the ERKs accumulate in the nucleus following activation (9, 27, 66). Similarly, it has been reported by several groups that
JNK accumulates in the nucleus following activation (8, 40,
51). In contrast to the activation-induced nuclear accumulation of the ERK MAPKs, the ERK activators MEK1 and MEK2 are cytoplasmic enzymes (1). A nuclear export sequence in the
NH2-terminal region of MEK1 appears to mediate rapid export
out of the nucleus and, therefore, the accumulation of MEK1 in the
cytoplasm (22, 23, 39). In contrast, we found that the JNK
activator MKK7 was present in both the cytoplasm and the nucleus (Fig.
10). This nuclear location was observed for endogenous MKK7 (Fig. 10A)
and for multiple MKK7 isoforms (Fig. 10B). Nuclear localization was also observed for the JNK activator MKK4. The mechanism that accounts for the nuclear location of MKK4 and MKK7 is unclear because the sequences of these protein kinases do not include an obvious nuclear localization sequence. It is possible that the absence of an NES may
contribute to the localization of MKK4 and MKK7 in the nucleus. Thus,
the subcellular location of the JNK activators MKK4 and MKK7 differs
from that of the ERK activators MEK1 and MEK2.
Recent studies indicate that the subcellular organization of the p38
MAPK pathway differs from that of both the ERK and JNK signaling
pathways. The major p38 MAPK activators (MKK3 and MKK6), like the
activators of ERK (MEK1 and MEK2), are both preferentially located in
the cytoplasm (5). However, unlike ERK, which exhibits activation-induced redistribution from the cytoplasm to the nucleus, the p38 MAPK is prelocalized in the nucleus and is rapidly exported to
the cytoplasm upon activation (5). The mechanism of nuclear export appears to be mediated, at least in part, by the nuclear substrate MAPKAP kinase 2, which is also exported from the nucleus following activation (5, 16). Together, these data indicate that there are marked differences between the subcellular organization of the ERK, JNK, and p38 MAPK pathways.
The presence of MKK4 and MKK7 in the nucleus suggests that these MAPKK
may activate JNK in this compartment of the cell. Indeed, Mizukami et
al. (51) have recently reported that JNK may be activated in
the nucleus during ischemia-reperfusion injury to the heart. However,
it is possible that MKK4 and MKK7 may also activate JNK in the
cytoplasm. Evidence in favor of this hypothesis was obtained from
studies of mutated MKK7 protein kinases that are excluded from the
nucleus (Fig. 11). We found that cytoplasmic MKK7 protein kinases
efficiently activated JNK in vivo (Fig. 11D) and that the activated JNK
in these cells accumulated in the nucleus (Fig. 11B). These data
indicate that MKK7 (and possibly MKK4) can activate JNK in the
cytoplasm and that the activated JNK redistributes from the cytoplasm
to the nucleus.
The presence of MKK4 and MKK7 in the nuclei of quiescent and stimulated
cells indicates that these MKK isoforms may also be activated in the
nucleus. Fanger et al. have reported that MEKK1 is located in the
nucleus (20). However, other MAPKKK that activate the
JNK signaling pathway appear to be preferentially located in the
cytoplasm. For example, MLK2 is detected in punctate structures along microtubules (56), MEKK2 and MEKK3 are located on
Golgi-associated vesicles (20), while MLK3 and DLK were
identified in the cytoplasm by immunofluorescence microscopy (data not
shown). The cytoplasmic location of these MAPKKKs raises questions
concerning the mechanism of action of nuclear MKK4 and MKK7. Clearly
MAPKKKs and MAPKKs must interact and therefore have to be present in
the same cellular compartment. The simplest explanation is that
although MKK4 and MKK7 are present in the nucleus, a cytoplasmic
population of molecules may arise from rapid shuttling across the
nuclear membrane. This model implies that some MAPKKKs (e.g., MEKK1)
may directly activate MKK4 and MKK7 in the nucleus, whereas others
(e.g., MLK3) may activate a cytoplasmic population of MKK4 and MKK7
that rapidly shuttles to the nucleus.
Further studies are required to identify the mechanisms used to
determine the subcellular distribution of components of the JNK
signaling pathway. Such mechanisms may include scaffold proteins that
interact with JNK and MKK7 (82). The expression of scaffold proteins may contribute to the selective control of JNK signaling in
specialized differentiated cells.
 |
ACKNOWLEDGMENTS |
We thank N. Ahn, J. Avruch, J. Blenis, S. Gutkind, H. Saito, U. Siebenlist, and T. Tan for providing reagents, and we thank K. Gemme
for administrative assistance.
This work was supported by grant CA53896 from the National Cancer
Institute. R.J.D. is an Investigator of the Howard Hughes Medical Institute.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Howard Hughes
Medical Institute, Program in Molecular Medicine, University of
Massachusetts Medical School, 373 Plantation St., Worcester, MA 01605. Phone: (508) 856-6054. Fax: (508) 856-3210. E-mail:
roger.davis{at}ummed.edu.
 |
REFERENCES |
| 1.
|
Ahn, N. G.,
R. Seger, and E. G. Krebs.
1992.
The mitogen-activated protein kinase activator.
Curr. Opin. Cell Biol.
4:992-999[Medline].
|
| 2.
|
Anafi, M.,
F. Kiefer,
G. D. Gish,
G. Mbamalu,
N. N. Iscove, and T. Pawson.
1997.
SH2/SH3 adaptor proteins can link tyrosine kinases to a Ste20-related protein kinase, HPK1.
J. Biol. Chem.
272:27804-27811[Abstract/Free Full Text].
|
| 3.
|
Bagrodia, S.,
B. Derijard,
R. J. Davis, and R. A. Cerione.
1995.
Cdc42 and PAK-mediated signaling leads to Jun kinase and p38 mitogen-activated protein kinase activation.
J. Biol. Chem.
270:27995-27998[Abstract/Free Full Text].
|
| 4.
|
Bardwell, L., and J. Thorner.
1996.
A conserved motif at the amino termini of MEKs might mediate high-affinity interaction with the cognate MAPKs.
Trends Biochem. Sci.
21:373-374[Medline].
|
| 5.
|
Ben-Levy, R.,
S. Hooper,
R. Wilson,
H. F. Paterson, and C. J. Marshall.
1998.
Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2.
Curr. Biol.
8:1049-1057[Medline].
|
| 6.
|
Blank, J. L.,
P. Gerwins,
E. M. Elliott,
S. Sather, and G. L. Johnson.
1996.
Molecular cloning of mitogen-activated protein/ERK kinase kinases (MEKK) 2 and 3. Regulation of sequential phosphorylation pathways involving mitogen-activated protein kinase and c-Jun kinase.
J. Biol. Chem.
271:5361-5368[Abstract/Free Full Text].
|
| 7.
|
Burbelo, P. D.,
D. Drechsel, and A. Hall.
1995.
A conserved binding motif defines numerous candidate target proteins for both Cdc42 and Rac GTPases.
J. Biol. Chem.
270:29071-29074[Abstract/Free Full Text].
|
| 8.
|
Cavigelli, M.,
F. Dolfi,
F.-X. Claret, and M. Karin.
1995.
Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation.
EMBO J.
14:5957-5964[Medline].
|
| 9.
|
Chen, R. H.,
C. Sarnecki, and J. Blenis.
1992.
Nuclear localization and regulation of erk- and rsk-encoded protein kinases.
Mol. Cell. Biol.
12:915-927[Abstract/Free Full Text].
|
| 10.
|
Coso, O. A.,
M. Chiariello,
J. C. Yu,
H. Teramoto,
P. Crespo,
N. Xu,
T. Miki, and J. S. Gutkind.
1995.
The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway.
Cell
81:1137-1146[Medline].
|
| 11.
|
Deacon, K., and J. L. Blank.
1997.
Characterization of the mitogen-activated protein kinase kinase 4 (MKK4)/c-Jun NH2-terminal kinase 1 and MKK3/p38 pathways regulated by MEK kinases 2 and 3.
J. Biol. Chem.
272:14489-14496[Abstract/Free Full Text].
|
| 12.
|
Dérijard, B.,
M. Hibi,
I.-H. Wu,
T. Barrett,
B. Su,
T. Deng,
M. Karin, and R. J. Davis.
1994.
JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.
Cell
76:1025-1037[Medline].
|
| 13.
|
Dérijard, B.,
J. Raingeaud,
T. Barrett,
I.-H. Wu,
J. Han,
R. J. Ulevitch, and R. J. Davis.
1995.
Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms.
Science
267:682-685[Abstract/Free Full Text].
|
| 14.
|
Dorow, D. S.,
L. Devereux,
E. Dietzsch, and T. De Kretser.
1993.
Identification of a new family of human epithelial protein kinases containing two leucine/isoleucine-zipper domains.
Eur. J. Biochem.
213:701-710[Medline].
|
| 15.
|
Ellinger-Ziegelbauer, H.,
K. Brown,
K. Kelly, and U. Siebenlist.
1997.
Direct activation of the stress-activated protein kinase (SAPK) and extracellular signal-regulated protein kinase (ERK) pathways by an inducible mitogen-activated protein Kinase/ERK kinase kinase 3 (MEKK) derivative.
J. Biol. Chem.
272:2668-2674[Abstract/Free Full Text].
|
| 16.
|
Engel, K.,
A. Kotlyarov, and M. Gaestel.
1998.
Leptomycin B-sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation.
EMBO J.
17:3363-3371[Medline].
|
| 17.
|
English, J. M.,
C. A. Vanderbilt,
S. Xu,
S. Marcus, and M. H. Cobb.
1995.
Isolation of MEK5 and differential expression of alternatively spliced forms.
J. Biol. Chem.
270:28897-28902[Abstract/Free Full Text].
|
| 18.
|
Fan, G.,
S. E. Merritt,
M. Kortenjann,
P. E. Shaw, and L. B. Holzman.
1996.
Dual leucine zipper-bearing kinase (DLK) activates p46SAPK and p38MAPK but not ERK2.
J. Biol. Chem.
271:24788-24793[Abstract/Free Full Text].
|
| 19.
|
Fanger, G. R.,
P. Gerwins,
C. Widmann,
M. B. Jarpe, and G. L. Johnson.
1997.
MEKKs, GCKs, MLKs, PAKs, TAKs, and Tpls: upstream regulators of the c-Jun amino-terminal kinases.
Curr. Opin. Genet. Dev.
7:67-74[Medline].
|
| 20.
|
Fanger, G. R.,
N. L. Johnson, and G. L. Johnson.
1997.
MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42.
EMBO J.
16:4961-4972[Medline].
|
| 21.
|
Foltz, I. N.,
R. E. Gerl,
J. S. Wieler,
M. Luckach,
R. A. Salmon, and J. W. Schrader.
1998.
Human mitogen-activated protein kinase kinase 7 (MKK7) is a highly conserved c-Jun N-terminal Kinase/Stress-activated protein kinase (JNK/SAPK) activated by environmental stresses and physiological stimuli.
J. Biol. Chem.
273:9344-9351[Abstract/Free Full Text].
|
| 22.
|
Fukuda, M.,
I. Gotoh,
M. Adachi,
Y. Gotoh, and E. Nishida.
1997.
A novel regulatory mechanism in the mitogen-activated protein (MAP) kinase cascade. Role of nuclear export signal of MAP kinase kinase.
J. Biol. Chem.
272:32642-32648[Abstract/Free Full Text].
|
| 23.
|
Fukuda, M.,
I. Gotoh,
Y. Gotoh, and E. Nishida.
1996.
Cytoplasmic localization of mitogen-activated protein kinase kinase directed by its NH2-terminal, leucine-rich short amino acid sequence, which acts as a nuclear export signal.
J. Biol. Chem.
271:20024-20028[Abstract/Free Full Text].
|
| 24.
|
Ganiatsas, S.,
L. Kwee,
Y. Fujiwara,
A. Perkins,
T. Ikeda,
M. A. Labow, and L. I. Zon.
1998.
SEK1 deficiency reveals mitogen-activated protein kinase cascade crossregulation and leads to abnormal hepatogenesis.
Proc. Natl. Acad. Sci. USA
95:6881-6886[Abstract/Free Full Text].
|
| 25.
|
Gerwins, P.,
J. L. Blank, and G. L. Johnson.
1997.
Cloning of a novel mitogen-activated protein kinase kinase kinase, MEKK4, that selectively regulates the c-Jun amino terminal kinase pathway.
J. Biol. Chem.
272:8288-8295[Abstract/Free Full Text].
|
| 26.
|
Glise, B.,
H. Bourbon, and S. Noselli.
1995.
hemipterous encodes a novel Drosophila MAP kinase kinase, required for epithelial cell sheet movement.
Cell
83:451-461[Medline].
|
| 27.
|
Gonzalez, F. A.,
A. Seth,
D. L. Raden,
D. S. Bowman,
F. S. Fay, and R. J. Davis.
1993.
Serum-induced translocation of mitogen-activated protein kinase to the cell surface ruffling membrane and the nucleus.
J. Cell Biol.
122:1089-1101[Abstract/Free Full Text].
|
| 28.
|
Han, J.,
J.-D. Lee,
Y. Jiang,
Z. Li,
L. Feng, and R. J. Ulevitch.
1996.
Characterization of the structure and expression of a novel MAP kinase kinase (MKK6).
J. Biol. Chem.
271:2886-2891[Abstract/Free Full Text].
|
| 29.
|
Han, Z. S.,
H. |